Abzena is a biologics research partner that specializes in the selection, development, and manufacture of biopharmaceutical products across North America, Europe, and internationally. The company offers a broad range of services and technologies, including antibody drug conjugate (ADC) linker technologies, antibody humanization, and protein deimmunisation. Abzena provides solutions for antibody discovery and development, immunogenicity assessment, and custom assays, including in vitro evaluations to assess cytokine storm risks. Their capabilities extend to antibody and protein engineering, ADC production, and comprehensive bioassay and bioanalytical services. The company also focuses on mammalian manufacturing and peptide synthesis, catering to biopharmaceutical companies and academic groups. Established in 2014 and headquartered in Cambridge, United Kingdom, Abzena has positioned itself as an essential partner in the biopharmaceutical industry, facilitating the development of innovative biologics and bioconjugates from concept to clinical application.
PacificGMP Inc. is a contract manufacturing organization, engages in developing and manufacturing biologics. It produces monoclonal antibodies, recombinant proteins, vaccine products, insect cell/baculovirus, anchorage and suspension cells, and gene therapy products.
PolyTherics has focused on technology development in the area of biomedical polymers for therapeutic applications. The most advanced of its techniques, site-specific PEGylation or TheraPEG, is being exploited in partnership with companies developing biopharmaceuticals. PolyTherics is also committed to developing its own pipeline of optimised clinical candidates.
Antitope Ltd is a biotechnology research company, develops non-immunogenic protein therapeutics.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.